Cancer Diagnostic Test Articles & Analysis

1 articles found

Nanostics Announces the Launch of its Bladder Cancer Clinical Study Identifying Disease Predictors for Early Detection of Bladder Cancer

The aim of the study is to validate a novel and minimally invasive liquid biopsy test for bladder cancer diagnosis using Nanostics’ ClarityDX® diagnostic platform. ...

Jul. 20, 2022

ByNanostics Inc.

Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you